AAAAAA

   
Results: 1-19 |
Results: 19
INCREASED RISK OF CATHETER COLONIZATION AND CATHETER-RELATED INFECTIONS IN SEVERE IMMUNOCOMPROMIZED PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE GLUCOCORTICOID TREATMENT
Authors: GOLDSCHMIDT H SALWENDER HJ HAHN U HEGENBART U EGERER G WALLMEIER M JANSEN B HAAS R
Citation: H. Goldschmidt et al., INCREASED RISK OF CATHETER COLONIZATION AND CATHETER-RELATED INFECTIONS IN SEVERE IMMUNOCOMPROMIZED PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE GLUCOCORTICOID TREATMENT, Zentralblatt fur Bakteriologie, 287(1-2), 1998, pp. 125-134
DECREASED NUMBERS OF CIRCULATING B-CELLS IN MYELOMA PATIENTS WITH REDUCTION AFTER CONVENTIONAL CHEMOTHERAPY
Authors: KALLMEYER C WALLMEIER M KIEL K MOOS M HEGENBART U HAAS R GOLDSCHMIDT H
Citation: C. Kallmeyer et al., DECREASED NUMBERS OF CIRCULATING B-CELLS IN MYELOMA PATIENTS WITH REDUCTION AFTER CONVENTIONAL CHEMOTHERAPY, American journal of hematology, 57(4), 1998, pp. 287-292
LEUKAPHERESIS PRODUCTS IN MULTIPLE-MYELOMA - LOWER TUMOR LOAD AFTER MOBILIZATION WITH CYCLOPHOSPHAMIDE PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) COMPARED WITH G-CSF ALONE
Authors: CREMER FW KIEL K WALLMEIER M HAAS R GOLDSCHMIDT H MOOS M
Citation: Fw. Cremer et al., LEUKAPHERESIS PRODUCTS IN MULTIPLE-MYELOMA - LOWER TUMOR LOAD AFTER MOBILIZATION WITH CYCLOPHOSPHAMIDE PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) COMPARED WITH G-CSF ALONE, Experimental hematology, 26(10), 1998, pp. 969-975
FIRST AND 2ND APHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA - NO DIFFERENCES IN TUMOR LOAD AND HEMATOPOIETIC STEM-CELL YIELD
Authors: KIEL K CREMER FW EHRBRECHT E WALLMEIER M HEGENBART U GOLDSCHMIDT H MOOS M
Citation: K. Kiel et al., FIRST AND 2ND APHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA - NO DIFFERENCES IN TUMOR LOAD AND HEMATOPOIETIC STEM-CELL YIELD, Bone marrow transplantation, 21(11), 1998, pp. 1109-1115
LEUKAPHERESIS PRODUCTS (LP) IN MULTIPLE-MYELOMA - LOWER TUMOR LOAD AFTER MOBILIZATION WITH CYCLOPHOSPHAMIDE (CY) PLUS G-CSF COMPARED TO G-CSF ALONE
Authors: CREMER FW KIEL K WALLMEIER M HAAS R GOLDSCHMIDT H MOOS M
Citation: Fw. Cremer et al., LEUKAPHERESIS PRODUCTS (LP) IN MULTIPLE-MYELOMA - LOWER TUMOR LOAD AFTER MOBILIZATION WITH CYCLOPHOSPHAMIDE (CY) PLUS G-CSF COMPARED TO G-CSF ALONE, Bone marrow transplantation, 21, 1998, pp. 726-726
FIRST AND 2ND APHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA - NO DIFFERENCES IN TUMOR LOAD AND HEMATOPOIETIC STEM-CELL YIELD
Authors: KIEL K CREMER FW EHRBRECHT E WALLMEIER M GOLDSCHMIDT H MOOS M
Citation: K. Kiel et al., FIRST AND 2ND APHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA - NO DIFFERENCES IN TUMOR LOAD AND HEMATOPOIETIC STEM-CELL YIELD, British Journal of Haematology, 102(1), 1998, pp. 72-72
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFTING IN MULTIPLE-MYELOMA (MM)
Authors: GOLDSCHMIDT H HEGENBART U WALLMEIER M FRUEHAUF S HOHAUS S WANNENMACHER M HAAS R
Citation: H. Goldschmidt et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFTING IN MULTIPLE-MYELOMA (MM), European journal of cancer, 33, 1997, pp. 404-404
A QUANTITATIVE PCR ASSAY FOR THE DETECTION OF LOW AMOUNTS OF MALIGNANT-CELLS IN MULTIPLE-MYELOMA
Authors: CREMER FW KIEL K WALLMEIER M GOLDSCHMIDT H MOOS M
Citation: Fw. Cremer et al., A QUANTITATIVE PCR ASSAY FOR THE DETECTION OF LOW AMOUNTS OF MALIGNANT-CELLS IN MULTIPLE-MYELOMA, Annals of oncology, 8(7), 1997, pp. 633-636
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
Authors: GOLDSCHMIDT H HEGENBART U WALLMEIER M HOHAUS S ENGENHART R WANNENMACHER M HAAS R
Citation: H. Goldschmidt et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA, Annals of oncology, 8(3), 1997, pp. 243-246
HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA
Authors: GOLDSCHMIDT H HEGENBART U WALLMEIER M MOOS M HAAS R
Citation: H. Goldschmidt et al., HIGH-DOSE CHEMOTHERAPY IN MULTIPLE-MYELOMA, Leukemia, 11, 1997, pp. 27-31
MALIGNANT-LYMPHOMA - PATHOLOGY, DIAGNOSIS , THERAPY
Authors: GOLDSCHMIDT H WALLMEIER M HEGENBART U HAAS R
Citation: H. Goldschmidt et al., MALIGNANT-LYMPHOMA - PATHOLOGY, DIAGNOSIS , THERAPY, Radiologe, 37(1), 1997, pp. 1-9
FACTORS INFLUENCING COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATINGFACTOR IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: GOLDSCHMIDT H HEGENBART U WALLMEIER M HOHAUS S HAAS R
Citation: H. Goldschmidt et al., FACTORS INFLUENCING COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATINGFACTOR IN PATIENTS WITH MULTIPLE-MYELOMA, British Journal of Haematology, 98(3), 1997, pp. 736-744
FIRST AND 2ND APHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA - NO DIFFERENCES IN TUMOR LOAD AND HEMATOPOIETIC STEM-CELL YIELD
Authors: KIEL K CREMER FW EHRBRECHT E WALLMEIER M GOLDSCHMIDT H MOOS M
Citation: K. Kiel et al., FIRST AND 2ND APHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA - NO DIFFERENCES IN TUMOR LOAD AND HEMATOPOIETIC STEM-CELL YIELD, Blood, 90(10), 1997, pp. 4224-4224
LEUKAPHERESIS PRODUCTS IN MULTIPLE-MYELOMA - LOWER TUMOR LOAD AFTER MOBILIZATION WITH CYCLOPHOSPHAMIDE PLUS G-CSF COMPARED TO G-CSF IN STEADY-STATE
Authors: CREMER FW KIEL K WALLMEIER M HAAS R GOLDSCHMIDT H MOOS M
Citation: Fw. Cremer et al., LEUKAPHERESIS PRODUCTS IN MULTIPLE-MYELOMA - LOWER TUMOR LOAD AFTER MOBILIZATION WITH CYCLOPHOSPHAMIDE PLUS G-CSF COMPARED TO G-CSF IN STEADY-STATE, Blood, 90(10), 1997, pp. 435-435
TREATMENT WITH VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE (VAD) ON OUTPATIENT BASIS IN MULTIPLE-MYELOMA
Authors: EGERER G HEGENBART U WALLMEIER M HAHN U HAAS R GOLDSCHMIDT H HUNSTEIN W
Citation: G. Egerer et al., TREATMENT WITH VINCRISTINE, ADRIAMYCIN AND DEXAMETHASONE (VAD) ON OUTPATIENT BASIS IN MULTIPLE-MYELOMA, Blood, 88(10), 1996, pp. 3603-3603
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND AUTOGRAFTING FOLLOWING HIGH-DOSE THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: GOLDSCHMIDT H HAAS R HEGENBART U WALLMEIER M HOHAUS S WANNENMACHER M HUNSTEIN W
Citation: H. Goldschmidt et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION AND AUTOGRAFTING FOLLOWING HIGH-DOSE THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA (MM), Blood, 88(10), 1996, pp. 512-512
PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM) SHOW A LOW NUMBER OF CIRCULATING B-CELLS IN PERIPHERAL-BLOOD WITH SIGNIFICANT REDUCTION AFTER VAD CHEMOTHERAPY
Authors: WALLMEIER M KALLMEYER C KIEL K MOOS M HEGENBART U HAAS R GOLDSCHMIDT H HUNSTEIN W
Citation: M. Wallmeier et al., PATIENTS WITH ADVANCED MULTIPLE-MYELOMA (MM) SHOW A LOW NUMBER OF CIRCULATING B-CELLS IN PERIPHERAL-BLOOD WITH SIGNIFICANT REDUCTION AFTER VAD CHEMOTHERAPY, Blood, 88(10), 1996, pp. 1551-1551
PBPC MOBILIZATION IN MULTIPLE-MYELOMA - HIGH-DOSE CHEMOTHERAPY PLUS G-CSF VS 2 DIFFERENT DOSAGES OF G-CSF DURING STEADY-STATE
Authors: GOLDSCHMIDT H HEGENBART U CREMER F KIEL K WALLMEIER M HOHAUS S HAAS R MOOS M
Citation: H. Goldschmidt et al., PBPC MOBILIZATION IN MULTIPLE-MYELOMA - HIGH-DOSE CHEMOTHERAPY PLUS G-CSF VS 2 DIFFERENT DOSAGES OF G-CSF DURING STEADY-STATE, Blood, 88(10), 1996, pp. 1610-1610
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PRETREATED PATIENTS WITH MULTIPLE-MYELOMA - A SIGNIFICANTLY LOWER B-CELL CONTENT IN LEUKAPHERESIS PRODUCTS FOLLOWING 7 G M(2) COMPARED TO 7 G/M(2) CYCLOPHOSPHAMIDE/
Authors: GOLDSCHMIDT H HEGENBART U WALLMEIER M HAAS R HUNSTEIN W
Citation: H. Goldschmidt et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PRETREATED PATIENTS WITH MULTIPLE-MYELOMA - A SIGNIFICANTLY LOWER B-CELL CONTENT IN LEUKAPHERESIS PRODUCTS FOLLOWING 7 G M(2) COMPARED TO 7 G/M(2) CYCLOPHOSPHAMIDE/, Blood, 86(10), 1995, pp. 1596-1596
Risultati: 1-19 |